Fabtech Technologies Stage Strong Q1 FY27 Turnaround: Net Profit Hits ₹421 Crore as Global Revenue Climbs

Fabtech Technologies Limited has published its consolidated unaudited financial results for the first quarter ended June 30, 2026 (Q1 FY27). The turn-key pharmaceutical and engineering solutions provider executed a significant performance turnaround, swinging from a net loss in the corresponding quarter of the previous year to positive bottom-line profitability.

Financial Performance Overview (Q1 FY27 vs Q1 FY26)

Revenue from Operations: Grew 10.26% YoY to ₹7,498.41 lakh in Q1 FY27, compared to ₹6,800.68 lakh in Q1 FY26 (and ₹15,852.44 lakh in Q4 FY26).

Total Income: Stood at ₹7,815.01 lakh (supported by Other Income of ₹316.60 lakh), up 18.49% YoY against ₹6,595.19 lakh in Q1 FY26.

Profit Before Tax (PBT): Climbed to ₹525.31 lakh, achieving a complete reversal from a pre-tax loss of ₹(619.47) lakh in Q1 FY26.

Tax Provision: Total tax expense for the quarter stood at ₹104.28 lakh (Current tax of ₹118.77 lakh and Deferred tax credit of ₹(14.49) lakh).

Net Profit After Tax (PAT): Reached ₹421.03 lakh, bouncing back from a Net Loss of ₹(612.59) lakh reported in Q1 FY26.

Total Comprehensive Income: Reported at ₹418.67 lakh (reflecting a minor OCI adjustment of ₹(2.36) lakh), compared to a loss of ₹(615.95) lakh in Q1 FY26.

Earnings Per Share (EPS): Basic and Diluted EPS turned positive to ₹0.95 per equity share (face value ₹10 each), up from ₹(1.89) in Q1 FY26 and ₹5.75 in Q4 FY26.

Operating Expense Highlights

Consolidated expenses for the quarter dropped 5.28% YoY to ₹7,289.23 lakh (versus ₹7,695.43 lakh in Q1 FY26), reflecting tighter operational control:

Purchase of Stock-in-Trade: Stood at ₹3,226.51 lakh (down from ₹3,591.02 lakh in Q1 FY26).

Changes in Inventories: Accounted for ₹935.03 lakh (versus ₹714.85 lakh in Q1 FY26).

Employee Benefits Expense: Stood at ₹1,021.89 lakh (versus ₹1,051.79 lakh in Q1 FY26).

Finance Costs: Stood at ₹85.97 lakh (versus ₹84.11 lakh in Q1 FY26).

Depreciation & Amortisation: Amounted to ₹129.55 lakh (versus ₹139.31 lakh in Q1 FY26).

Other Expenses: Controlled at ₹1,890.28 lakh (versus ₹2,064.35 lakh in Q1 FY26).

Geographic Revenue Breakdown & Trade Receivables

Fabtech Technologies' global footprint spans multiple key pharmaceutical markets across Asia and Africa.

Segment Revenue (Gross & Net)

 Q1 FY27 REVENUE BY GEOGRAPHY
 +--------------------+---------------------+---------------------+
 | Region | Q1 FY27 (INR Lakh) | Q1 FY26 (INR Lakh) |
 +--------------------+---------------------+---------------------+
 | Saudi Arabia | 1,713.70 | 713.95 |
 | Morocco | 1,680.58 | 2,200.91 |
 | India | 1,198.43 | 1,070.23 |
 | Kenya | 1,113.18 | - |
 | UAE | 1,059.58 | 404.21 |
 | Rest of the World | 1,316.62 | 1,690.14 |
 +--------------------+---------------------+---------------------+
 | Gross Total | 8,082.09 | 7,528.53 |
 | Less: Inter-Segment| (583.68) | (727.85) |
 +--------------------+---------------------+---------------------+
 | Net Revenue | 7,498.41 | 6,800.68 |
 +--------------------+---------------------+---------------------+

Segment Trade Receivables & Assets

As of June 30, 2026, total trade receivables (including unbilled revenue) stood at ₹21,488.20 lakh:

Saudi Arabia: ₹7,576.63 lakh

UAE: ₹4,012.07 lakh

India: ₹2,685.32 lakh

Rest of the World: ₹1,943.69 lakh

Kenya: ₹1,778.10 lakh

Morocco: ₹356.49 lakh

Tanzania (Unbilled Revenue): ₹45.49 lakh

Capital Base & Full-Year FY26 Context


Paid-Up Equity Share Capital: Expanded to ₹4,335.08 lakh (face value ₹10 per share) as of June 30, 2026, up from ₹3,239.22 lakh in Q1 FY26.

Other Equity: Stood at ₹37,531.88 lakh as per the audited balance sheet for the period ended March 31, 2026.

Full-Year FY26 Historical Benchmark: For the financial year ended March 31, 2026, Fabtech Technologies recorded:

Revenue from Operations: ₹41,077.18 lakh

Total Income: ₹43,132.95 lakh

Profit Before Tax: ₹4,827.41 lakh

Net Profit After Tax: ₹3,835.30 lakh

Full-Year EPS: ₹10.00

Key Highlights:

Resilient Revenue Growth: Despite a challenging macro environment marked by geopolitical uncertainties, war-like situations, and a sharp increase in freight costs, the Company delivered a 10% Year-on-Year (YoY) revenue growth, standing at ₹74.98 crores for Q1 FY27 (compared to ₹68.01 crores in Q1 FY26).

Profitability Turnaround: The Company achieved a consolidated Net Profit (PAT) of ₹4.21 crores in Q1 FY27, a robust turnaround from a Net Loss of ₹6.13 crores in Q1 FY26.

Operating Margins (EBITDA): Consolidated EBITDA for Q1 FY27 was ₹7.41 crores with a healthy EBITDA margin of 9.5%, a strong recovery from the negative EBITDA (-₹5.27 crores) in Q1 FY26.

Strategic Geographic Growth & Localisation: The overall 10% YoY consolidated revenue growth masks significant underlying shifts in the Company's geographical mix. The return to profitability was entirely driven by the stellar performance of the KSA operations, a massive scale-up in Africa, and a strong standalone turnaround in the core FTL business, which successfully offset severe regional headwinds in the UAE (FTS) segment. Africa emerged as a key growth engine, with new markets like Morocco and Kenya contributing a combined ₹27.94 crores in Q1 FY27, while Saudi Arabia registered a stellar 130% YoY growth (reaching ₹17.14 crores). This reflects the resounding success of our regional diversification and "becoming local" strategy. Moving forward, the Company plans to strategically invest further in its international subsidiaries to ensure deeper localization, faster execution, and sustained market penetration.

Robust Order Book & Visibility: Sustained by dynamic cycle of execution and new order inflow, the Group's open order book stood robust at over ₹900 crores as of June 30, 2026. Complementing this firm order book, out of total active enquiries exceeding ₹9,300 crores, the team is currently advancing 'hot leads' worth over ₹3,800 crores, providing exceptionally strong business visibility over the next two years. The Company is actively pursuing several large-ticket opportunities in our key markets, which are expected to strengthen the order book upon conversion. While the current geopolitical situation has temporarily delayed the finalization of certain orders, there have been no cancellations, and customer engagement remains highly active.

Cost of Goods Sold (COGS) & Contribution Margin: Total COGS (Purchase of Stockin-Trade + Changes in Inventories) decreased by 3.35% YoY to ₹41.62 crores in Q1 FY27 (down from ₹43.06 crores in Q1 FY26), despite the 10% increase in consolidated revenue. This disconnect between revenue growth and COGS reduction is driven by the geographical mix. This resulted in the consolidated Contribution Margin expanding from 37.6% (Q1 FY26) to a robust 46.7% (Q1 FY27).

Finance Costs: Finance costs witnessed a sharp 36% YoY reduction, dropping to ₹0.86 crores from ₹1.34 crores. This significant savings is primarily on account of efficient utilization of working capital and external borrowing facilities, facilitated by the strategic utilization of funds raised during the recent IPO. Furthermore, our strengthened balance sheet post-IPO has empowered the Company to negotiate much more favourable credit terms with our banking partners and actively optimize our overall working capital cycle which shall have impact going forward.

Shares of Fabtech Technologies Limited was last trading in BSE at Rs. 149.25 as compared to the previous close of Rs. 148.85. The total number of shares traded during the day was 10331 in over 260 trades.

The stock hit an intraday high of Rs. 152.50 and intraday low of 147.00. The net turnover during the day was Rs. 1545202.00.

Source : Equity Bulls

Keywords

FabtechTechnologies INE0HF201011 MedicalEquipment Supplies Q1FY27 Q1FY2027 ResultUpdate